
 Closing Bell Closing Bell: What’s Riding on Big Tech’s Big Reports? 10/29/24
 Oct 29, 2024 
 Dan Greenhaus from Solus Alternative Asset Management, Courtney Garcia of Payne Capital Management, Brian Belski from BMO, Katherine Stueland, CEO of GeneDX, and Doug Clinton of Intelligent Alpha delve into the mega-cap tech landscape. They discuss the urgency surrounding Alphabet's upcoming earnings amid fierce competition and regulatory hurdles. Stueland also shares GeneDX's success in pediatric genetic diagnostics and their innovative approach to genetic testing. Insights into mid-cap investments and AI's impact on market dynamics provide listeners with valuable takeaways. 
 Chapters 
 Transcript 
 Episode notes 
 1  2  3  4  5  6 
 Intro 
 00:00 • 1min 
 Navigating Alphabet's Earnings and Market Challenges 
 01:28 • 14min 
 Navigating Mid-Cap Investments 
 15:46 • 7min 
 Balancing Patient Care and Profitability in Healthcare 
 22:58 • 1min 
 Transforming Pediatric Healthcare with Genetic Testing 
 24:26 • 5min 
 AI and Earnings: Tech Titans' Next Moves 
 29:00 • 15min 
